The Evolving Landscape of Cancer Modeling
March 2-5, 2020
Hard Rock Hotel
San Diego, California
Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, New York
Andrea Califano, Columbia University Medical School, New York, New York
Jos Jonkers, Netherlands Cancer Institute, Amsterdam, Netherlands
Calvin J. Kuo, Stanford University, Stanford, California
The AACR is closely monitoring the continuing developments with the Novel Coronavirus. We want to assure anyone planning to attend any AACR meeting that their safety and security are our top priority.
Based on all available information, at this time there is no plan to cancel or postpone any of the scheduled AACR meetings.
We are following the guidance of the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) in regard to travel and event management. In addition, we are closely monitoring all travel alerts issued by the U.S. Department of Homeland Security, and recommendations and policies developed by our peer groups and other large scientific societies.
We will also take proactive steps at all our meetings, such as adding hand sanitizer stations throughout the meeting venue. We encourage attendees to monitor the CDC website for additional information and review and follow the WHO’s Travel Advice, as well as its recommendations for protecting themselves from an infection.
If you have any questions or need further information, please call AACR at +1-215-440-9300 or email email@example.com.
A veritable explosion of cancer models in recent years has been fueled by technological advances that have enabled the rapid generation of models of increasing complexity and relevance for human cancer. Genetically engineered mouse (GEM) models and cancer cell lines are mainstays for basic and translational cancer research; organoids and patient-derived xenograft (PDX) models are allowing for a better recapitulation of cancer characteristics; and cell-based computational modeling simulates single-cell behavior in virtual tissues of cancer systems. These next-generation models have, in turn, provided key insights into all aspects of cancer biology, including elucidating the actions of stem cells and developmental pathways and the impact of lineage plasticity, understanding metastatic progression, uncovering the roles of the tumor microenvironment and immune system, exploring tumor evolution, and discovering new therapeutic approaches and mechanisms of drug sensitivity and adaptive response. This meeting will highlight recent advances in modeling cancer using mouse models, cell lines, organoids, PDX models, and computational models, focusing on their impact for advancing our understanding of cancer biology, prevention and treatment, and drug response and resistance.View Exhibitor Prospectus Brochure
For information on tabletop exhibits please contact firstname.lastname@example.org. Space is limited.